Astera Labs, Inc. (NASDAQ:ALAB) Shares Bought by Dakota Wealth Management

Dakota Wealth Management raised its position in Astera Labs, Inc. (NASDAQ:ALAB) by 2.5% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 43,110 shares of the company’s stock after acquiring an additional 1,049 shares during the quarter. Dakota Wealth Management’s holdings in Astera Labs were worth $5,710,000 as of its most recent filing with the SEC.

Other institutional investors also recently bought and sold shares of the company. ORG Wealth Partners LLC acquired a new position in Astera Labs in the 4th quarter valued at $42,000. Hollencrest Capital Management acquired a new position in Astera Labs in the 3rd quarter valued at $26,000. GAMMA Investing LLC increased its stake in Astera Labs by 78.3% in the 4th quarter. GAMMA Investing LLC now owns 510 shares of the company’s stock valued at $68,000 after buying an additional 224 shares during the period. US Bancorp DE acquired a new position in Astera Labs in the 3rd quarter valued at $46,000. Finally, First Horizon Advisors Inc. acquired a new position in Astera Labs in the 3rd quarter valued at $49,000. 60.47% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several brokerages have issued reports on ALAB. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Astera Labs from $60.00 to $100.00 and gave the company a “buy” rating in a research note on Tuesday, November 5th. JPMorgan Chase & Co. upped their price target on shares of Astera Labs from $70.00 to $110.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 5th. Northland Securities cut shares of Astera Labs from an “outperform” rating to a “market perform” rating and upped their price target for the stock from $100.00 to $120.00 in a research note on Thursday, January 2nd. Barclays upped their price target on shares of Astera Labs from $87.00 to $135.00 and gave the stock an “overweight” rating in a research note on Friday, January 17th. Finally, Morgan Stanley cut shares of Astera Labs from an “overweight” rating to an “equal weight” rating and set a $142.00 price target on the stock. in a research note on Tuesday. Three research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $109.75.

Insider Buying and Selling at Astera Labs

In other Astera Labs news, Director Manuel Alba sold 11,000 shares of the company’s stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $117.50, for a total value of $1,292,500.00. Following the transaction, the director now directly owns 456,863 shares in the company, valued at approximately $53,681,402.50. This represents a 2.35 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Michael Truett Tate sold 16,000 shares of the stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of $117.84, for a total transaction of $1,885,440.00. Following the transaction, the chief financial officer now owns 1,412,888 shares in the company, valued at approximately $166,494,721.92. The trade was a 1.12 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 1,690,452 shares of company stock worth $167,581,256.

Astera Labs Trading Down 1.2 %

Astera Labs stock opened at $122.95 on Thursday. Astera Labs, Inc. has a 52 week low of $36.22 and a 52 week high of $147.39. The firm’s 50-day simple moving average is $121.05 and its 200 day simple moving average is $77.75.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Monday, November 4th. The company reported $0.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.17 by $0.06. The company had revenue of $113.10 million for the quarter, compared to analyst estimates of $97.50 million. Astera Labs had a negative net margin of 30.69% and a negative return on equity of 15.57%. The firm’s revenue for the quarter was up 47.1% on a year-over-year basis. As a group, sell-side analysts predict that Astera Labs, Inc. will post -0.45 EPS for the current fiscal year.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.